Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype
Autor/a
Adams, Paul
Altes, Albert
Brissot, Pierre
Butzeck, Barbara
Cabantchik, Ioav
Cançado, Rodolfo
Distante, Sonia
Evans, Patricia
Evans, Robert
Ganz, Tomas
Girelli, Domenico
Hultcrantz, Rolf
McLaren, Gordon
Marris, Ben
Milman, Nils
Nemeth, Elizabeta
Nielsen, Peter
Pineau, Brigitte
Piperno, Alberto
Porto, Graça
Prince, Dianne
Ryan, John
Sanchez, Mayka
Santos, Paulo
Swinkels, Dorine
Teixeira, Emerência
Toska, Ketil
Vanclooster, Annick
White, Desley
Contributors and Hemochromatosis International Taskforce
Fecha de publicación
2018ISSN
1936-0533
Resumen
Although guidelines are available for hereditary hemochromatosis, a high percentage of the recommendations within them are not shared between the different guidelines. Our main aim is to provide an objective, simple, brief, and practical set of recommendations about therapeutic aspects of HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype, based on the published scientific studies and guidelines, in a form that is reasonably comprehensible to patients and people without medical training. This final version was approved at the Hemochromatosis International meeting on 12th May 2017 in Los Angeles.
Tipo de documento
Artículo
Versión del documento
Versión publicada
Lengua
English
Materias (CDU)
61 - Medicina
Palabras clave
Medicina
Medicine
Páginas
3
Publicado por
Springer Nature
Colección
12
Publicado en
Hepatology International
Citación
Adams, Paul; Altes, Albert; Brissot, Pierre [et al.]. Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype. Hepatology International, 2018, 12, p. 83-86. Disponible en: <https://link.springer.com/article/10.1007/s12072-018-9855-0>. Fecha de acceso: 31 ene. 2024. DOI: 10.1007/s12072-018-9855-0
Este ítem aparece en la(s) siguiente(s) colección(ones)
- Ciències de la Salut [738]
Derechos
© 2018 Springer Nature